Skip to main content

Table 1 Patients’ characteristics before transplantation

From: Treatment of bone loss in patients with chronic liver disease awaiting liver transplantation

 

IBA

Age (years)

54.1±9.5

Total (n)

31

Female/male

9 / 22

Liver disease

cholestatic:

2

non-cholestatic:

29

T-score lumbar spine

( 0 – -1 normal range)

-1.77±1.51

T-score femoral neck

-1.21±1.24

Bone specific alkaline phosphatase (8-16.6 μg/l)

18.61±8.74

Pyridinoline

(95 – 215 μg/g creatinine)

311±180

Desoxypridinoline (15 – 45 μg/g creatinine)

46.01±28.2

  1. IBA, ibandronate.